Cost Effectiveness of Sirolimus-Eluting Stents Compared with Bare Metal Stents in Acute Myocardial Infarction: Insights from the TYPHOON Trial

Background Drug-eluting stents have been shown to reduce the rate of repeat revascularization after percutaneous coronary intervention for acute myocardial infarction (AMI) as compared with bare metal stents (BMS). A few studies have reported the cost effectiveness of sirolimus-eluting stents (SES) in several countries, but none in the particular setting of AMI in France.